(Q36243745)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16129368%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

0 references

1 reference

title

P53 as a prognostic marker for bladder cancer: a meta-analysis and review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16129368%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16129368%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Diana Puente

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16129368%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Francisco X Real

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16129368%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

author name string

Aurelia Bustos

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16129368%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Cristiane M Nascimento

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16129368%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Francisco Fernandez

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16129368%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Manuel Rivas

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16129368%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Manolis Kogevinas

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16129368%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

language of work or name

1 reference

1 September 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16129368%20AND%20SRC:MED&resulttype=core&format=json

Lancet Oncology Commission

6 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16129368%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16129368%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

page(s)

678-686

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16129368%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16129368%20AND%20SRC:MED&resulttype=core&format=json

Primary superficial bladder cancer risk groups according to progression, mortality and recurrence.

6 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970315-6

7 January 2021

Multivariate analysis of the prognostic factors of primary superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970315-6

7 January 2021

What we could do now: molecular pathology of bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970315-6

7 January 2021

Evaluation and follow-up strategies for superficial bladder cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970315-6

7 January 2021

Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970315-6

7 January 2021

Surfing the p53 network

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970315-6

7 January 2021

p53 immunohistochemistry as a prognostic marker in bladder cancer. Playground for urology scientists?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970315-6

7 January 2021

Accumulation of nuclear p53 and tumor progression in bladder cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970315-6

7 January 2021

Biological markers in superficial bladder tumors and their prognostic significance

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970315-6

7 January 2021

A critical analysis of the use of p53 as a marker for management of bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970315-6

7 January 2021

Can p53 staining be used to identify patients with aggressive superficial bladder cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970315-6

7 January 2021

The International Bladder Cancer Bank: proposal for a new study concept

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970315-6

7 January 2021

Assessing TP53 status in human tumours to evaluate clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970315-6

7 January 2021

Over-expression of p53 nuclear oncoprotein in transitional-cell bladder cancer and its prognostic value

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970315-6

7 January 2021

P53 expression, ploidy and progression in pT1 transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970315-6

7 January 2021

Association of P53 nuclear overexpression and tumor progression in carcinoma in situ of the bladder.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970315-6

7 January 2021

p53 mutations have no additional prognostic value over stage in bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970315-6

7 January 2021

p53 and Rb immunostaining in locally advanced bladder cancer: relation to prognostic variables and predictive value for the local response to radical radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970315-6

7 January 2021

Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVAC

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970315-6

7 January 2021

Relationship of p53 and bcl-2 to prognosis in muscle-invasive transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970315-6

7 January 2021

Overexpression of p53 protein in a high-risk population of patients with superficial bladder cancer before and after bacillus Calmette-Guérin therapy: correlation to clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970315-6

7 January 2021

Long-term efficacy of intravesical bacillus Calmette-Guerin for carcinoma in situ: relationship of progression to histological response and p53 nuclear accumulation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970315-6

7 January 2021

The prognostic value of p53 nuclear overexpression and MIB-1 as a proliferative marker in transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970315-6

7 January 2021

Alterations of TP53 in microdissected transitional cell carcinoma of the human urinary bladder: high frequency of TP53 accumulation in the absence of detected mutations is associated with poor prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970315-6

7 January 2021

Predictive value of p53 and pRb immunostaining in locally advanced bladder cancer treated with cystectomy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970315-6

7 January 2021

Bcl-2 and p53 expressions in invasive bladder cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970315-6

7 January 2021

The prevalence of bcl-2, p53, and Ki-67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathologic correlates

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970315-6

7 January 2021

Can p53 nuclear over-expression, Bcl-2 accumulation and PCNA status be of prognostic significance in high-risk superficial and invasive bladder tumours?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970315-6

7 January 2021

Clinical significance of mdm2 and p53 expression in bladder cancer. A comparison with cell proliferation and apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970315-6

7 January 2021

Structural alteration of p53 protein in patients with muscle invasive bladder transitional cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970315-6

7 January 2021

Correlation of immunohistochemical molecular staging of bladder biopsies and radical cystectomy specimens

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970315-6

7 January 2021

Proapoptotic genes BAX and CD40L are predictors of survival in transitional cell carcinoma of the bladder.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970315-6

7 January 2021

P53 protein expression in transitional cell carcinoma of the bladder - experience of the University of Malaya Medical Centre

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970315-6

7 January 2021

Ki-67 index enhances the prognostic accuracy of the urothelial superficial bladder carcinoma risk group classification

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970315-6

7 January 2021

Prognostic value of MIB-1 score, p53, EGFr, mitotic index and papillary status in primary superficial (Stage pTa/T1) bladder cancer: a prospective comparative study. The Finnbladder Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970315-6

7 January 2021

Patterns of multiple recurrences of superficial (Ta/T1) transitional cell carcinoma of bladder and effects of clinicopathologic and biochemical factors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970315-6

7 January 2021

Numerical chromosomal aberrations in muscle invasive squamous cell and transitional cell cancer of the urinary bladder: an alternative to classic prognostic indicators?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970315-6

7 January 2021

Prognostic value of proliferative activity and nuclear morphometry for progression in TaT1 urothelial cell carcinomas of the urinary bladder

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970315-6

7 January 2021

Overexpression of p53 protein and its significance for recurrent progressive bladder tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970315-6

7 January 2021

Clinical significance of thymidylate synthase expression in bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970315-6

7 January 2021

p53 mutations in human bladder cancer: genotypic versus phenotypic patterns

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970315-6

7 January 2021

A dynamic role of HAUSP in the p53-Mdm2 pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970315-6

7 January 2021

A population-based study of immunohistochemical detection of p53 alteration in bladder cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970315-6

7 January 2021

2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970315-6

7 January 2021

Dangers of using "optimal" cutpoints in the evaluation of prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970315-6

7 January 2021

Users' Guides to the Medical Literature

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970315-6

7 January 2021

Meta-analysis of the literature or of individual patient data: is there a difference?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970315-6

7 January 2021

A systematic review and evaluation of the use of tumour markers in paediatric oncology: Ewing's sarcoma and neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970315-6

7 January 2021

p53 and RB: simple interesting correlates or tumor markers of critical predictive nature?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970315-6

7 January 2021

Traditional reviews, meta-analyses and pooled analyses in epidemiology

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970315-6

7 January 2021

Prognostic markers of intravesical bacillus Calmette-Guérin therapy for multiple, high-grade, stage T1 bladder cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970315-6

7 January 2021

Effect of p21WAF1/CIP1 expression on tumor progression in bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970315-6

7 January 2021

p53 nuclear accumulation is not associated with decreased disease-free survival in patients with node positive transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970315-6

7 January 2021

Prognostic value of MCM2 immunoreactivity in stage T1 transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970315-6

7 January 2021

Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970315-6

7 January 2021

Prognostic value of the expression of E-cadherin and β-catenin in bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970315-6

7 January 2021

Serum anti-p53 antibodies and p53 protein status in the sera and tumors from bladder cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970315-6

7 January 2021

10.1016/S1470-2045(05)70315-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16129368%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference